CHRONOBIOLOGICAL INVESTIGATION OF TNF AND IL-2
TNF 和 IL-2 的时间生物学研究
基本信息
- 批准号:3195411
- 负责人:
- 金额:$ 9.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-06 至 1994-06-30
- 项目状态:已结题
- 来源:
- 关键词:albino mouse animal population study antineoplastic antibiotics cellular immunity chronotherapy circadian rhythms drug adverse effect immunopharmacology interleukin 2 metastasis neoplasm /cancer immunotherapy neoplasm /cancer transplantation nonhuman therapy evaluation pituitary adrenal axis seasons sex cycle tumor necrosis factor alpha
项目摘要
It is proposed to investigate the circadian stage dependency of the
toxicities, biologic activities and anticancer activities of recombinant
human Tumor Necrosis Factor (rhTNF) and Interleukin 2 (rhIL-2) in the
Balb/c mouse with and without an implanted Meth-A sarcoma. We have found
preliminarily that the circadian time and season of tumor inoculation
affect both tumor take rate and natural killer cell activity. We have also
found that the timing of tumor resection within the fertility cycle affects
the frequency of subsequent metastatic tumor spread and that the fertility
cycle affects the level of immunocyte NK activity. Therefore, the effects
of female fertility cycle stage and season at time of study will also be
quantified.
The biological effects of most, if not all, trophic hormones are dependent
to some extent upon the temporal patterning of their release or administra-
tion. Fertility depends upon the pulsatility of FSH and LH delivery from
the pituitary to the ovary and testis. Cortisol release depends intimately
upon both the high frequency pulsing and the circadian patterning of ACTH
delivery from the pituitary to the adrenal glands. IL-1 is a centrally
positioned cytokine having synergistic activities with TNF and interactive
or stimulatory effects upon several other cytokines and growth factors.
Glucocorticoids (which are exquisitely circadian rhythmic) modulate the
dynamics of IL-1 gene transcription rate, messenger RNA stability and
resultant translation rate and IL-1 cellular release rate, as well as TNF-
induced cytotoxicity. IL-1, in turn, modulates glucocorticoid receptor
binding, decreases available binding sites and reduces steroid-associated
enzyme induction. These steroid/cytokine interactions suggest that
chronobiologic investigation of cytokine toxicity and anticancer efficacy
may be important.
The toxic and therapeutic anticancer effects of many cytotoxic xenobiotic
anticancer agents depend upon their circadian timing. Reproducible peak-
trough circadian differences in toxicity and anticancer activity usually
range between 50% and 250%. Preliminary data on tumor necrosis factor
indicate that the circadian stage dependent differences in toxic/therapeut-
ic ratio may be of substantially higher magnitude for cytokines.
Specific hypotheses to be addressed by the proposed research include: 1)
Endogenous, reproducible, nontrivial and quantifiable circadian rhythms (
which are reproducibly modulated by both the fertility cycle and season)
characterize (murine and human) normal biology; 2) Population synchrony,
gauged by reference to sleep-wake schedules and physiologic circadian
marker rhythms, may be used to extrapolate phase relationships appropriate-
ly from individual and species to species; 3) Endogenous activity of
natural immunologic defense networks have rhythmic circadian, fertility
cycle and seasonal variation; 4) The hypophyseal-adrenal network is an
important circadian coordinator of cellular immune networks; 5) These
networks have rhythmic circadian, fertility cycle and seasonal variation in
their ability to be stimulated; 6) The circadian timing of TNF reproducibly
affects its toxicity and its antitumor efficacy; 7) The circadian timing of
IL-2 reproducibly affects its toxicity and its antitumor efficacy.
建议调查昼夜节律的依赖
重组的毒性,生物活动和抗癌活性
人类肿瘤坏死因子(RHTNF)和白介素2(RHIL-2)
带有和没有植入的甲虫的BALB/C小鼠。 我们找到了
首先是肿瘤接种的昼夜节律时间和季节
影响肿瘤的患病率和天然杀伤细胞活性。 我们也有
发现在生育周期内肿瘤切除的时机会影响
随后的转移性肿瘤的频率扩散和生育能力
循环影响免疫细胞NK活性的水平。 因此,效果
在学习时的女性生育周期阶段和季节也将是
量化。
大多数(如果不是全部)营养激素的生物学作用取决于
在某种程度上,其释放或行政的时间模式
tion。 生育能力取决于FSH和LH传递的脉动
卵巢和睾丸的垂体。 皮质醇释放密切取决于
在高频脉冲和艾克斯的昼夜节律上
从垂体到肾上腺的递送。 IL-1是一个中央
定位具有与TNF和Interactive协同活性的细胞因子
或对其他几种细胞因子和生长因子的刺激作用。
糖皮质激素(精美的昼夜节律)调节
IL-1基因转录率,信使RNA稳定性和
由此产生的翻译率和IL-1细胞释放速率,以及TNF-
诱导的细胞毒性。 IL-1反过来调节糖皮质激素受体
结合,减少可用的结合位点并减少类固醇相关的
酶诱导。 这些类固醇/细胞因子相互作用表明
细胞因子毒性和抗癌功效的时间生物学研究
可能很重要。
许多细胞毒性异生元的有毒和治疗性抗癌作用
抗癌剂取决于他们的昼夜节律。 可重复的峰 -
昼夜节日毒性和抗癌活性的差异通常
范围在50%至250%之间。 肿瘤坏死因子的初步数据
表明昼夜阶段依赖于有毒/疗法的差异
对于细胞因子,IC比可能具有更高的幅度。
拟议的研究要解决的具体假设包括:1)
内源性,可重现,非平地和可量化的昼夜节律(
这是通过生育周期和季节可重复调节的)
表征(鼠和人类)正常生物学; 2)人口同步,
参考睡眠觉醒时间表和生理昼夜节律进行评估
标记节奏可用于推断适当的相位关系 -
从个人和物种到物种; 3)内源性活性
自然免疫防御网络具有节奏昼夜节律,生育能力
周期和季节性变化; 4)垂体 - 肾上腺肾上腺网络是
细胞免疫网络的重要昼夜节律协调员; 5)这些
网络具有有节奏的昼夜节律,生育周期和季节性变化
他们的刺激能力; 6)TNF的昼夜节律可重复
影响其毒性及其抗肿瘤功效; 7)昼夜节律的时机
IL-2可重复影响其毒性及其抗肿瘤功效。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
- DOI:
- 发表时间:1998-06
- 期刊:
- 影响因子:2.6
- 作者:P. Wood;W. Hrushesky;R. Klevecz
- 通讯作者:P. Wood;W. Hrushesky;R. Klevecz
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome.
候选基因和途径的发现可能有助于解释生育周期阶段依赖的乳腺癌切除后结果。
- DOI:10.1007/s10549-008-0253-5
- 发表时间:2009
- 期刊:
- 影响因子:3.8
- 作者:Oh,Eun-Young;Wood,PatriciaA;Yang,Xiaoming;Hrushesky,WilliamJM
- 通讯作者:Hrushesky,WilliamJM
Menstrual cycle timing of breast cancer resection.
乳腺癌切除术的月经周期时机。
- DOI:10.1007/978-3-642-79278-6_4
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Hrushesky,WJ
- 通讯作者:Hrushesky,WJ
Larry Scheving and cancer chronotherapy.
拉里·谢文和癌症时间疗法。
- DOI:
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Hrushesky,WJ
- 通讯作者:Hrushesky,WJ
Cancer chronotherapy: is there a right time in the day to treat?
癌症时间疗法:一天中是否有合适的时间进行治疗?
- DOI:
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Hrushesky,WJ
- 通讯作者:Hrushesky,WJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM JM HRUSHESKY其他文献
WILLIAM JM HRUSHESKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM JM HRUSHESKY', 18)}}的其他基金
COBRE: VAMC: PATHOLOGY CORE, COLON CANCER
COBRE:VAMC:病理学核心,结肠癌
- 批准号:
7381894 - 财政年份:2006
- 资助金额:
$ 9.14万 - 项目类别:
COBRE: VAMC: PATHOLOGY CORE, COLON CANCER
COBRE:VAMC:病理学核心,结肠癌
- 批准号:
7171120 - 财政年份:2005
- 资助金额:
$ 9.14万 - 项目类别:
COBRE: VAMC: PATHOLOGY CORE, COLON CANCER
COBRE:VAMC:病理学核心,结肠癌
- 批准号:
6981798 - 财政年份:2004
- 资助金额:
$ 9.14万 - 项目类别:
CHRONOBIOLOGICAL INVESTIGATION OF TNF AND IL-2
TNF 和 IL-2 的时间生物学研究
- 批准号:
3195409 - 财政年份:1990
- 资助金额:
$ 9.14万 - 项目类别:
CHRONOBIOLOGICAL INVESTIGATION OF TNF AND IL-2
TNF 和 IL-2 的时间生物学研究
- 批准号:
3195410 - 财政年份:1990
- 资助金额:
$ 9.14万 - 项目类别:
CLINICAL APPLICATION OF CHRONOBIOLOGY TO CANCER MEDICINE
时间生物学在癌症医学中的临床应用
- 批准号:
3169732 - 财政年份:1982
- 资助金额:
$ 9.14万 - 项目类别:
相似国自然基金
ω-3多不饱和脂肪酸对2型糖尿病人群和模型动物高密度脂蛋白亚组分和动脉粥样硬化影响及机制研究
- 批准号:81872618
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
野生哺乳动物和人群中沙粒病毒的分子流行病学研究
- 批准号:81702016
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于大样本平行人群及动物模型的NAFLD代谢组学研究
- 批准号:81573133
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
基于One Health理念建立动物职业暴露人群流感监测体系的研究
- 批准号:81473034
- 批准年份:2014
- 资助金额:60.0 万元
- 项目类别:面上项目
导致发热伴血小板减少综合征的新型病毒在不同人群、宿主动物及媒介中感染分布的动态研究
- 批准号:81102171
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Maximizing Hearing Recovery from Peri-Synaptic Damage
最大限度地提高突触周围损伤的听力恢复能力
- 批准号:
10348676 - 财政年份:2020
- 资助金额:
$ 9.14万 - 项目类别:
Maximizing Hearing Recovery from Peri-Synaptic Damage
最大限度地提高突触周围损伤的听力恢复能力
- 批准号:
10552577 - 财政年份:2020
- 资助金额:
$ 9.14万 - 项目类别:
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma
调节肠道微生物组以增强胰腺腺癌免疫治疗的疗效
- 批准号:
10010686 - 财政年份:2020
- 资助金额:
$ 9.14万 - 项目类别: